Sirius Medical

Name

Sirius Medical

Legal name

Sirius Medical Systems B.V.

Website

https://sirius-medical.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Surgical Navigation Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG)

akta.pro secondary industries

Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)

Keywords

• Surgical marker navigation
• Breast tumor localization
• Magnetic surgical markers
• Intraoperative tumor guidance
• Medical device navigation

Headquarters

HQ city

Eindhoven

HQ country

Netherlands

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Pintuition Probe Console and Software System: Sale of the Pintuition Probe console and GPSDetect software system to hospitals and surgical centers, typically as capital equipment purchases or recurring service agreements.
2. Pintuition Marker (Consumable): Recurring sales of the Pintuition Marker — a single-use implantable device placed at the tumor site pre-operatively. Each surgical procedure requires one marker, creating a recurring per-procedure revenue stream alongside the capital system sale.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Sirius Medical develops and sells the Pintuition System, a wire-free, radiation-free magnetic surgical marker navigation platform for breast-conserving surgery. The system comprises a single-use implantable magnetic Pintuition Marker (consumable), a multi-sensor Pintuition Probe (console), and GPSDetect navigation software that delivers real-time visual and audio directional guidance to surgeons during tumor excision. Revenue is generated from capital equipment sales of the probe console/software and recurring per-procedure sales of the single-use Pintuition Marker.

Product overview

Sirius Medical offers the Sirius Pintuition surgical marker navigation system, a wire-free localization technology for breast cancer surgery. The core system consists of the Pintuition Marker (a magnetic surgical marker), Pintuition System (with Slim Probe and standard Probe variants), and GPSDetect software providing real-time directional guidance. Key features include TargetLOC for probe alignment and SIRIUSLINK for pathway assessment. The system is CE marked, FDA cleared, and MDR certified, enabling tumor localization with flexible pre-operative scheduling and millimeter-level precision.

Differentiator

Problem solved

Functional benefit

Brands

• Sirius Pintuition: Surgical marker navigation system for tumor localization in breast cancer surgery, powered by GPSDetect software providing real-time directional guidance.
• GPSDetect
• Pintuition Marker
• TargetLOC

Products and services

• Sirius Pintuition System Capital equipment surgical marker navigation system consisting of the Pintuition Probe (with multi-sensor technology) and GPSDetect software, providing real-time directional audio and visual guidance for precise tumor localization during breast-conserving surgery. Sold to hospitals and surgical centers.
• Pintuition Marker Single-use, nickel-free biocompatible titanium-encapsulated magnetic surgical marker implanted at the tumor site pre-operatively. Generates a magnetic field detectable by the Pintuition Probe, enabling wire-free, radiation-free intraoperative localization. Each breast-conserving surgery requires one marker, creating a per-procedure consumable revenue stream.
• Pintuition Slim Probe

Quantifiable outcome

• Over 70,000 procedures performed using the Pintuition System globally
• +3 more outcomes

Named customers7 records

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered minor and flagship.

• MedteqminorChannel Partner/ Reseller/ Distributor · 1 January 2023Distribution partnership with Medteq covering the Greek and Cypriot markets. Medteq serves as the local distributor for the Pintuition System, providing market access and customer support in these regions where Mammotome does not have exclusive coverage.
• MammotomeflagshipChannel Partner/ Reseller/ Distributor · 1 January 2021Exclusive distribution agreement for the Pintuition System in the US and several key European markets (Germany, Italy, Poland). Mammotome is a leading provider of breast disease diagnosis and surgical solutions with deep relationships in the breast cancer care pathway. The partnership leverages Mammotome's established sales force and hospital network to rapidly scale Pintuition System adoption. Announced expanded to Italy and Poland alongside the Series B funding announcement in 2023.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Hologic: Hologic acquired SCOUT, a wire-free radar localization system for breast tumor localization, and also owns the Magseed magnetic marker (via the Endomag acquisition in 2023). Hologic is the largest direct competitor to Sirius Medical's Pintuition System in the breast surgical localization market, offering comparable wire-free, radiation-free alternatives with significantly larger commercial reach and hospital relationships.
• Merit Medical Systems: Merit Medical markets the Savi Scout, a wire-free, radiation-free reflector-based localization system for breast-conserving surgery (acquired via Cianna Medical). Savi Scout competes head-to-head with Pintuition in US and European breast surgery markets, with an established installed base and broader procedural cardiology/peripheral vascular portfolio providing scale advantages.

Emerging players

• Molli Surgical: Molli Surgical has developed a wire-free, radiation-free breast tumor localization system using a small magnetic marker detectable by a handheld probe. Like Sirius Medical, Molli targets the wire-guided localization replacement opportunity with a similar technology profile, but is at an earlier commercial stage with a narrower hospital footprint.
• Elucent Medical: Elucent Medical develops wire-free, radiation-free localization technologies (SmartClip and SmartTag systems) for breast and soft tissue surgical guidance. It competes with Pintuition in the same clinical indication and customer base but is a smaller, earlier-stage player with more limited clinical evidence and commercial reach.
• CairnSurgical: CairnSurgical has developed the Breast Cancer Locator (BCL), a patient-specific, 3D-printed surgical guidance platform for breast-conserving surgery. While it uses a different technology approach (3D-printed form rather than real-time magnetic navigation), it targets the same breast surgeons, the same indication, and the same workflow-replacement opportunity as Pintuition.

Broad incumbents

• Brainlab: Brainlab is a leading surgical navigation and digital surgery software company with broad intraoperative guidance platforms used across neurosurgery, orthopedic, ENT, and increasingly breast/soft tissue surgery. Its broad surgical navigation portfolio, capital installed base, and global hospital footprint position it as a broader incumbent in the surgical navigation category where Pintuition competes.
• Stryker: Stryker's surgical navigation and instrumentation portfolio spans orthopedic, neuro, ENT, and increasingly surgical oncology workflows. While Stryker does not currently offer a direct breast localization competitor to Pintuition, its navigation technology stack, capital salesforce, and global hospital relationships make it a strategically relevant broad incumbent in surgical marker navigation.
• Medtronic: Medtronic is one of the largest diversified medical device companies with broad surgical, oncology, and patient monitoring franchises. Although Medtronic does not have a direct breast localization product competing with Pintuition, its global hospital sales infrastructure, capital equipment reach, and breast care pathway presence make it a strategically comparable broad incumbent in the surgical oncology space.
• Leica Microsystems (Danaher): Leica Microsystems, part of Danaher's life sciences and diagnostics platform, provides surgical microscopy, intraoperative imaging, and digital surgery solutions used in oncology and reconstructive surgery workflows. While Leica's portfolio is microscope/imaging-focused rather than marker-based, it serves the same surgical oncology customer base and competes for capital equipment budgets alongside Pintuition at major academic centers.

Others

• Mammotome (a division of Danaher/Leica Biosystems): Mammotome is the exclusive distribution partner for Sirius Medical's Pintuition System in the US, Germany, Italy, and Poland. Mammotome also develops and markets its own breast biopsy and surgical solutions, making it both a commercial channel and a partial adjacent competitor. Its dominant hospital relationships across the breast cancer pathway are a strategic asset that materially shapes Sirius's go-to-market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xtwitter.com/SiriusMedical
• LinkedInlinkedin.com/company/sirius-medical

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds4 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sirius Medical